Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion (Q44247144)
Jump to navigation
Jump to search
scientific article published in August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion |
scientific article published in August 2013 |
Statements
1 reference
Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion (English)
1 reference
Zhen Huan Cao
1 reference
Li Na Ma
1 reference
Hong Wei Zhang
1 reference
Ya Li Liu
1 reference
Xin Yue Chen
1 reference
1 August 2013
1 reference
1 reference
14
1 reference
8
1 reference
446-450
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference